Brief report: Validation of a quantitative HIV risk prediction tool using a national HIV testing cohort
- PMID: 25585300
- PMCID: PMC4357562
- DOI: 10.1097/QAI.0000000000000518
Brief report: Validation of a quantitative HIV risk prediction tool using a national HIV testing cohort
Abstract
Routine screening is recommended for HIV detection. HIV risk estimation remains important. Our goal was to validate the Denver HIV Risk Score using a national cohort from the Centers for Disease Control and Prevention. Patients of 13 years and older were included, 4,830,941 HIV tests were performed, and 0.6% newly diagnosed infections were identified. Of all visits, 9% were very low risk (HIV prevalence = 0.20%), 27% low risk (HIV prevalence = 0.17%), 41% moderate risk (HIV prevalence = 0.39%), 17% high risk (HIV prevalence = 1.19%), and 6% very high risk (HIV prevalence = 3.57%). The Denver HIV Risk Score accurately categorized patients into different HIV risk groups.
Figures
References
-
- [Accessed August 21, 2008];Centers for Disease Control and Prevention - Division of HIV/AIDS Prevention. , at http://www.cdc.gov/hiv/topics/surveillance/basic.htm#hivest.)
-
- [Accessed September 27, 2011];National HIV/AIDS Strategy for the United States. 2010 , at http://www.whitehouse.gov/sites/default/files/uploads/NHAS.pdf.)
-
- Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55:1–17. quiz CE1-4. - PubMed
-
- Moyer VA. Screening for HIV: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine. 2013 N/A:N/A-N/A. - PubMed
-
- d'Almeida KW, Kierzek G, de Truchis P, et al. Modest Public Health Impact of Nontargeted Human Immunodeficiency Virus Screening in 29 Emergency Departments. Arch Intern Med. 2011 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical